LB Pharmaceuticals Inc Common Stock (LBRX) Financials

LBRX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 393.5 million 14.8 million
Dec. 31, 2025 312.9 million 11.6 million
Sept. 30, 2025 320.7 million 10.5 million
June 30, 2025 19.2 million 123.1 million

LBRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -23.3 million 2.6 million
Dec. 31, 2025 -18.1 million 2.3 million
Sept. 30, 2025 -3.4 million 881000
June 30, 2025 -6.9 million 484500

LBRX Net Income

No data available :(

LBRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 365.6 million - 2.7 million
Dec. 31, 2025 295.2 million - 2.8 million
Sept. 30, 2025 314.5 million - 2.9 million
June 30, 2025 14.2 million - 3.8 million

LBRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 28.2 million
Dec. 31, 2025 25.3 million
Sept. 30, 2025 25.3 million
June 30, 2025 251789

LBRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 32000 14.6 million 7.4 million -
Dec. 31, 2025 40000 8.5 million 5.4 million -
Sept. 30, 2025 - 2.4 million 2.8 million -
June 30, 2025 6000 2.9 million 2.6 million 141500

LBRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 82000
Dec. 31, 2025 - 85000
Sept. 30, 2025 - 81000
June 30, 2025 - -

LBRX

Price: $28.50

52 week price:
13.36
33.47

Earnings Per Share: -1.36 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 828.8 million

Links: